Loading
Loading
Biorank Laboratories
Chronic Pain Management
Educational purposes only. Not medical advice. Always consult your doctor before starting supplements.
Persistent pain lasting more than 3 months involving central sensitization, neuroinflammation, and neuroplastic changes
Alysa Analysis for
Chronic Pain Management
Priority Guide
Pro-resolving mediators (resolvins, protectins) actively reduce neuroinflammation. Meta-analyses show modest pain reduction across chronic pain conditions.
Recommended Dose
2-4g combined EPA/DHA daily
Expected Timeframe
8-12 weeks
NF-kB and COX-2 inhibitor. Multiple RCTs show comparable efficacy to NSAIDs for inflammatory pain with fewer side effects.
Recommended Dose
500-1000mg bioavailable curcumin daily
Expected Timeframe
4-8 weeks
NMDA receptor antagonist that reduces central sensitization. Deficiency lowers pain threshold.
Recommended Dose
300-400mg magnesium glycinate daily
Expected Timeframe
4-8 weeks
Endogenous fatty acid amide that modulates mast cells and glial activation. Multiple RCTs show pain reduction in neuropathic and inflammatory pain.
Recommended Dose
600-1200mg daily in divided doses
Expected Timeframe
4-8 weeks
No matching product in catalog yet. Search alternatives
3 of 4 supplements available in our database — add them all at once.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Always consult your doctor or qualified healthcare provider before starting any supplement regimen, especially if you have existing health conditions or take medications.
Supplements may interact with medications and are not intended to diagnose, treat, cure, or prevent any disease.
The evidence ratings reflect our analysis of published research and may not capture every nuance of individual health situations.